Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Feb;17(2):174-6.
doi: 10.1093/neuonc/nou314. Epub 2014 Dec 1.

Factorial clinical trials: a new approach to phase II neuro-oncology studies

Fabio M Iwamoto  1 , Andrew B Lassman  1
Affiliations
Editorial

Factorial clinical trials: a new approach to phase II neuro-oncology studies

Fabio M Iwamoto et al. Neuro Oncol. 2015 Feb.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Ostrom QT, Gittleman H, Farah P, et al. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States 2006–2010. Neuro Oncol. 2013;15(suppl. 2):ii1–ii56. - PMC - PubMed
    1. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New Engl J Med. 2005;352(10):987–996. - PubMed
    1. Chinot OL, Wick W, Mason W, et al. Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma. New Engl J Med. 2014;370(8):709–722. - PubMed
    1. Gilbert MR, Dignam JJ, Armstrong TS, et al. A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma. New Engl J Med. 2014;370(8):699–708. - PMC - PubMed
    1. Stupp R, Hegi ME, Gorlia T, et al. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071–22072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2014;15(10):1100–1108. - PubMed

MeSH terms